Skip to content

Author

Jane Ifeyinwa Anatuanya

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Beyond oxidative stress: Emerging molecular mechanisms and translational perspectives in environmental toxicant-induced hematotoxicity

Background: Environmental toxicants, including heavy metals, pesticides, particulate air pollutants, per- and polyfluoroalkyl substances (PFAS), and microplastics, are increasingly recognized as major contributors to hematological disorders. Although oxidative stress has traditionally been regarded as the principal mechanism underlying environmental toxicant-induced hematotoxicity, emerging evidence suggests that additional molecular pathways contribute substantially to hematopoietic injury. This review examines the evolving molecular mechanisms of environmental toxicant-induced hematotoxicity beyond the conventional oxidative stress paradigm and explores their translational implications. Methods: Literature was retrieved from PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar and synthesized through a structured narrative review. Evidence published primarily between 2020 and 2026 was critically evaluated and organized into thematic areas including oxidative stress, mitochondrial dysfunction, ferroptosis, pyroptosis, epigenetic reprogramming, immunometabolic dysregulation, hematopoietic stem-cell dysfunction, biomarker discovery, multi-omics technologies, artificial intelligence, and precision hematology. Findings: Environmental toxicant-induced hematotoxicity is mediated by a complex network of interacting molecular pathways rather than oxidative stress alone. Emerging evidence highlights important roles for mitochondrial dysfunction, ferroptosis, pyroptosis, epigenetic reprogramming, immunometabolic dysregulation, and hematopoietic stem-cell (HSC) impairment in regulating blood-cell homeostasis and bone marrow integrity. These pathways interact extensively with oxidative stress and contribute to disease heterogeneity, chronic toxicity, and variable clinical outcomes. Advances in multi-omics technologies and artificial intelligence further provide opportunities for biomarker discovery, improved risk assessment, and early disease detection. Conclusion: Environmental toxicant-induced hematotoxicity should be viewed as a systems-level disorder arising from coordinated interactions among multiple molecular pathways. Integrating mechanistic insights with multi-omics technologies, artificial intelligence (AI), and precision hematology may improve disease prediction, biomarker development, early diagnosis, and targeted intervention strategies. Novelty/Originality of this article: This review moves beyond the traditional oxidative stress paradigm by integrating emerging molecular mechanisms into a systems hematotoxicology framework for understanding environmental toxicant-induced hematological injury. It synthesizes evidence on mitochondrial dysfunction, ferroptosis, pyroptosis, epigenetic reprogramming, immunometabolic dysregulation, and hematopoietic stem-cell dysfunction while highlighting their translational relevance for biomarker discovery, multi-omics research, artificial intelligence, and precision hematology. This integrated perspective remains largely absent from conventional reviews that examine these mechanisms independently.

Esther Uyoyooghene Olokede, Favour Oluwadamilola Agboola, Jane Ifeyinwa Anatuanya et al. · 0 citations
Review Open access Aug 2026

CRISPR Functional Genomics in Precision Oncology: Integrating Single-Cell Multi-Omics for Cancer Vulnerability Discovery

Precision oncology seeks to identify patient-specific therapeutic vulnerabilities; however, conventional genomic profiling is limited by intratumoral heterogeneity and its inability to distinguish functional driver alterations from passenger mutations, often resulting in incomplete prediction of therapeutic response. Recently, the combination of CRISPR functional genomics with single-cell multi-omics has proven to be a paradigm-shifting strategy for understanding context-specific cancer vulnerabilities by causal functional interrogation. The aim of this review is to critically examine recent progress in the integration of these technologies for discovering vulnerabilities in cancer, and introduces a new conceptual model, called the Integrated Functional Precision Oncology (IFPO) Framework, that brings together functional genomic perturbation, single-cell multi-omics, computational systems biology, and clinical translation. Literature was retrieved from Pubmed, Web of Science and Google Scholar and peer reviewed studies published between 2020 and 2025. Key findings from historic and recent research were analyzed to pinpoint methodological innovations, translational studies, limitations, and areas in need of further research. The results reveal that the integrated CRISPR–single-cell platforms, such as Perturb-seq, CROP-seq, and ECCITE-seq, can be used to causally interrogate gene function at the single-cell level, allowing for the identification of context-dependent essential genes, synthetic lethal interactions, regulatory networks, and therapeutic resistance mechanisms. All the evidence suggests that therapeutic response is not merely a function of genomic alterations but also the dynamic interplay between genomic alterations, cellular state, epigenetic plasticity, and the tumor microenvironment. The proposed IFPO Framework integrates these findings into a systems-level model that captures the mechanisms by which these functional perturbations, multimodal molecular profiling, and AI-driven integration of data converge to reveal clinically actionable cancer vulnerabilities. This integrated paradigm transforms precision oncology from descriptive molecular profiling to functional systems oncology and offers directions for further progress of precision cancer treatment based on enhanced biomarker discovery, therapeutic target identification, and prospective clinical translation.

O. Oluwadare, M. Frankpeace, Oluwabukunmi M. Oluwaniran et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.